Особенности компонентного состава тела и физиометрических показателей у женщин с неалкогольной жировой болезнью печени

НАЖБП становится все более распространенным заболеванием, которое поражает более 25% взрослых людей во всем мире. Если специфическое обследование для выявления НАЖБП не проводится, это состояние обычно протекает бессимптомно до развития тяжелой и потенциально необратимой печеночной недостаточности. Поскольку начальная стадия НАЖБП не имеет клинических проявлений, малодиагностируема и чаще проявляется у женщин, целью нашего исследования было выявить некоторые особенности компонентного состава тела и физиометрических показателей, характерных для данной группы пациенток.

1. Ivashkin V. T., Maevskaya M. V., Zharkova M. S., Kotovskaya Yu.V., Tkacheva O. N., Troshina E. A. et al. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022; 32 (4): 104–140. (In Russ.). https://doi.org/10.22416/1382‑4376‑2022‑32‑4‑104‑140

2. Ding L., Oligschlaeger Y., Shiri-Sverdlov R., Houben T. (2020). Nonalcoholic Fatty Liver Disease. In: von Eckardstein A., Binder C. J. (eds) Prevention and Treatment of Atherosclerosis. Handbook of Experimental Pharmacology. Vol. 270. Springer, Cham. https://doi.org/10.1007/164_2020_352

3. Azzu V., Vacca M., Virtue S., Allison M., VidalPuig A. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology, 2020; 158 (7): 1899–1912. DOI: 10.1053/j.gastro.2019.12.054

4. Zaki M., Amin D., Mohamed R. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease. J Complement Integr Med. 2020 Dec 22; 18 (2): 385–390. DOI: 10.1515/jcim‑2020–0073. PMID: 34187121.

5. Tutelyan VA, Nikityuk DB, Burlyaeva EA and others. Using the method of complex anthropometry in sports and clinical practice: guidelines. M.: Sport, 2018. 49 p. (In Russ.).

6. Durnin J. V.G.A., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974; 32: 77–97.

7. Siri W. E. Body composition from fluid spaces and density: analyses of methods Techniques for measuring body composition, Natl Acad. Sci. National Res. Council, Washington DC,1961. P. 223–244.

8. Friedl K. E., Westphal K. A., Marchitelli L. J., Patton J. F., Chumlea W. C., Guo S. S. Evaluation of anthropometric equations to assess body-composition changes in young women. Am J Clin Nutr. 2001; 73: 268–275.

9. Feng W.-H., Bi Y., Li P., Yin T.-T., Gao C.-X., Shen S.-M. et al. Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial. Journal Diabetes Investig. 2019; 10 (2): 399–407. DOI: 10.1111/jdi.12888

10. Razmpour F., Daryabeygi-Khotbehsara R., Soleimani D. et al. Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices. Sci Rep. 2023; 13: 4942. https://doi.org/10.1038/s41598–023–32129-y

11. Miyake T., Miyazaki M., Yoshida O. et al. Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study. BMC Gastroenterol. 2021; 21: 170. https://doi.org/10.1186/s12876–021–01748-y

12. Kang S., Moon M. K., Kim W., Koo B. K. Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey. Journal of Cachexia, Sarcopenia and Muscle. 2020; 11 (5). DOI: 10.1002/jcsm.12598

13. Han E., Lee Y-H., Ahn S. H., B-S. Cha, Kim S. U., B-W. Lee Appendicular skeletal muscle mass to visceral fat area ratio predicts hepatic morbidities Gut and Liver. 2023; 18 (3). DOI: 10.5009/gnl230238

14. Zhang Y, Xiang L, Qi F, Cao Y, Zhang W, Lv T, Zhou X. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease. Front Endocrinol (Lausanne). 2024; 5 (15): 1322563. DOI: 10.3389/fendo.2024.1322563. PMID: 38375190; PMCID: PMC 10876088.

15. Cheah M. C.C., Crane H., George J. Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysis. Hepatol Int. 2025; 19 (3): 607–618. DOI: 10.1007/s12072-025-10801-x. Epub 2025 Mar 14. PMID: 40087205; PMCID: PMC 12137498.

16. Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014; 20 (28): 9330–9337 PMID: 25071327. DOI: 10.3748/wjg.v20.i28.9330

17. Zharikov Yu.O., Zharkova M. S., Gadzhiakhmedova A. N., Aliyeva A. M., Nikolenko V. N., Ivashkin V. T. Parameters of the Component Composition of the Body and Their Relationship with the Development of Ascites in Liver Cirrhosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2024; 34 (3): 53–61. (In Russ.). https://doi.org/10.22416/1382‑4376‑2024‑34‑3‑53‑61

18. Zharikov Yu.O., Maslennikov R. V., Zharikova T. S., Gadzhiakhmedova A. N., Alieva A. M., Nikolenko V.N., et al. The relationship between the active cell mass index and complications of liver cirrhosis: ascites and hepatic encephalopathy. Astrakhan medical journal. 2024; 19 (1): 66–75. (In Russ.). https://doi.org/10.17021/1992‑6499‑2024‑1‑66‑75

19. Ostrovskaya A. S., Maevskaya M. V. Sarcopenia and malnutrition in patients with liver diseases. Meditsinskiy sovet = Medical Council. 2023; (18): 35–42. (In Russ.). https://doi.org/10.21518/ms2023–374